Ouch! Teva Needs An IV, Stat By: Stocks to Watch November 02, 2017 at 10:07 AM EDT U.S. drug pricing is a challenge for Teva, whose latest earnings disappointed investors. Read More >> Related Stocks: Teva Pharmaceutical Industries ADR